Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A major fund trimmed a sizable stake in Manhattan Associates as the stock pulled back sharply. This article breaks do...
A notable stake in Magnite signals a contrarian take on the ad tech landscape. This article breaks down the move, wha...
Clean-energy demand keeps lifting the prices of platinum group metals. This report highlights the best performing pla...
A fund’s big move out of a top-performing pharma stock can puzzle investors. Here’s a clear, practical look at what k...
Alphabet is shifting from relying on Broadcom to building its own AI chips, aiming to feed GOOG’s hyperscale cloud wh...
Caterpillar has emerged as a heavyweight in the Dow, powered by AI-driven infrastructure demand and mining activity. ...
Mega IPOs grab headlines, but history often tells a different investing story. This article explains how spacex: hist...
Memory plays a critical role in AI growth, and micron's data center gross margin has surged to industry-leading level...
When Wells Fargo reports earnings, the spotlight isn’t just on per-share figures. The real story this quarter is net ...
A stock surged 125% in 2026, turning heads across the market. This deep-dive breaks down the drivers of the move, how...
When a beverage maker expands beyond a single hero brand, the investment narrative changes. Celsius transformed its g...